Jump to content

H. Lee Moffitt Cancer Center & Research Institute

From Wikipedia, the free encyclopedia
(Redirected from Moffitt Cancer Center)
Moffitt Cancer Center
and Research Institute
Moffitt Cancer Center Magnolia Campus with cancer hospital and research facilities
Magnolia - Main Campus
TypeNon-profit cancer treatment and research center
Established1986
FounderH. Lee Moffitt
AffiliationNational Cancer Institute-designated Comprehensive Cancer Center
PresidentPatrick Hwu, MD[1]
Location
Tampa, Florida
,
USA

27.7692739 -82.6412105
Websitemoffitt.org

Moffitt Cancer Center & Research Institute is a nonprofit cancer treatment and research center located in Tampa, Florida. Established in 1981 by the Florida Legislature, the hospital opened in October 1986 on the University of South Florida's campus.[2] Moffitt is one of two National Cancer Institute-designated Comprehensive Cancer Centers based in Florida.[3][4][5] In 2021, U.S. News & World Report ranked Moffitt Cancer Center as a top 30 cancer hospital in the United States.[6][7]

History

[edit]

Funding for construction of the initial $70 million facility came primarily from the state of Florida's cigarette tax, while the momentum to create the center came from a cadre of legislators, physicians, educators, and business leaders who envisioned a new dimension of cancer care and research in Florida.

In late 1978, H. Lee Moffitt, a Florida state representative, recognized the need for a comprehensive cancer center within the state after several friends died from cancer. An excellent negotiator, Moffitt put his plan into motion by first proposing the idea to Hollis Boren, then dean of the University of South Florida College of Medicine. Over lunch at the Tampa Club, Moffitt proposed his idea. By dessert, Boren has signed on. "Out of that discussion came plans for a plug-shaped, multilevel cancer research teaching hospital to be built a short walk away from the USF clinics," The Tampa Times reported on February 5, 1979. Moffitt and Boren had gathered information about the need for a comprehensive cancer center, the article said, and the need was great.[8][9]

Moffitt sought community support and convinced the State Legislature to fund the facility. During the center's planning phase, consultants associated with NCI-designated Cancer Centers were retained to ensure that the finished facility would be as technologically advanced and as efficiently designed as possible.

Groundbreaking ceremonies took place in January 1983. The center was incorporated in the spring of 1984 and was named for Houston Lee Moffitt, then Speaker of the State House of Representatives. The building was dedicated in October 1986 and admitted its first patients that same month.

In 1990, the acquisition of the Research Center building across from the Cancer Center enhanced the recruitment of scientists, clinicians, and support staff, and expanded Moffitt's vision beyond the original structure. The Moffitt Research Center became the focal point for basic and translational cancer research, with the overriding goal to produce discoveries that could be translated quickly from the bench to the patient's bedside. The Florida Legislature allocated $12 million for renovation and equipment for this 100,000-square-foot (9,300 m2) structure, and the Moffitt Research Center became fully operational in 1995. In 1999, 48,000 square feet (4,500 m2) of basic research lab space was added to the Moffitt Research Center at a cost of $11 million to house the growing need for additional scientists.

In 2022 the Florida Legislature approved more than $706 million for a new H. Lee Moffitt Cancer Center and Research Institute campus in Pasco County. $600 million in state funding will be distributed in yearly in $20 million yearly increments for each of the next 30 years.[10]

Organization

[edit]

On June 10, 1998, in a ceremonial signing at Moffitt, Florida governor Lawton Chiles approved a legislative initiative to fund construction of the Moffitt Tower Project, which opened in April 2003, adding more than 350,000 square feet (33,000 m2) of new space. This expansion includes the Vincent A. Stabile Research Building, eponymously named in recognition of the largest private donation ever made to the Cancer Center. The new construction also includes an expansion of the Moffitt Clinic. In addition to new research laboratories, which nearly double the cancer center's research capabilities, the new facilities include a digital imaging center, and a new infusion center.

In 1991, John Ruckdeschel, assumed the position of center director, president and CEO. Under Ruckdeschel's leadership, Moffitt became a National Cancer Institute (NCI) Comprehensive Cancer Center. In 2017,[11] the NCI renewed Moffitt's Cancer Center Support Grant for another five years. Currently, Moffitt receives more than $50 million annually in peer-reviewed grant monies.

In 2002, Ruckdeschel stepped down, and William Dalton, became Moffitt's third president, CEO and center director.

In 2008, the University of Florida and Shands at UF formed a partnership with Moffitt to develop programs in cancer care, research and prevention.[12][13][14]

In 2009, the University of South Florida and Moffitt were awarded $6 million in federal grant money to create the Center for Equal Health, a five-year partnership focused on addressing issues of cancer health disparities.[15][16]

Scientific programs include molecular oncology;, drug discovery; immunology; experimental therapeutics; computational biology of cancer; health outcomes; and behavior and risk assessment, detection and intervention. It also serves as the site for the Bill and Beverly Young National Functional Genomics Center, funded by the U.S. Department of Defense.

Moffitt Cancer Center is affiliated with the University of South Florida Morsani College of Medicine and provides education to medical students and residency training as well.[17][18]

On June 24, 2011, Moffitt Cancer Center opened the first blood and marrow transplant (BMT) clinic in Puerto Rico.[19]

On July 1, 2011, Moffitt Cancer Center opened a new 50,000-square-foot satellite facility at International Plaza. The building replaced Moffitt's former outpatient center at Tampa General Hospital.[20][21]

In July 2012, William Dalton, became the CEO of M2Gen and Moffitt's new Personalized Medicine Institute. Alan List, who previously served as Moffitt's executive vice president/physician-in-chief and president of the Moffitt Medical Group, succeeded Dalton as CEO and president. Thomas Sellers assumed the role of center director.[22]

In February 2013, Moffitt began construction of a $74.2 million outpatient facility on the cancer center's 30-acre property on N McKinley Drive, about a mile from Moffitt's main campus.[23]

In November 2015, Moffitt opens the McKinley Outpatient Center. The six-story, 207,000-square-foot facility at 10920 N McKinley Drive is located about a mile from the main campus. Services on the site include the skin and breast cancer clinics, four operating rooms, an imaging suite, research labs, space for blood draws and a Publix pharmacy.[24]

In July 2017, Moffitt and Memorial Healthcare announce a partnership to establish a comprehensive blood and marrow transplant cellular therapy program for South Florida residents. The alliance brings the renowned cancer center's access to research, clinical trials, and comprehensive treatment to leukemia, lymphoma and multiple myeloma patients.[25]

In August 2020, Moffitt named Patrick Hwu, a tumor immunologist with 33 years of oncology experience, its new president and CEO.[26]

Research and Treatment

[edit]

Through clinical trials, Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center at Moffitt, and researchers at Moffitt Cancer Center discovered two monotherapy drugs – Mekinist (trametinib) and Tafinlar (dabrafenib) – can be safely combined to overcome or delay treatment resistance for a large percentage of melanoma patients with a specific gene mutation. Approved by the FDA in January 2014, Mekinist in combination with Tafinlar is one of the biggest advancements in melanoma treatment in the past 30 years.[27]

In August 2011, the U.S. Food and Drug Administration (FDA) approved the drug vemurafenib (Zelboraf) for metastatic melanoma patients who test positive for a specific gene mutation. Moffitt Cancer Center conducted a registration trial using the drug manufactured by Genentech, a member of the Roche Group.[28]

Anna Giuliano, director of Moffitt's Center for Infection Research in Cancer, led two studies on human papillomavirus (HPV) infection in men. Her work strengthened the Food & Drug Administration (FDA) recommendation for boys and men to receive HPV vaccinations and provided useful data for the development of realistic cost-effectiveness models for male HPV vaccination internationally.[29]

In September 2014, a new cancer immunotherapy for melanoma patients called Keytruda became the first anti-PD-1 (programmed death receptor-1) therapy approved in the United States. Jeffrey Weber, director of the Donald A. Adam Comprehensive Melanoma Research Center of Excellence at Moffitt, was one of the lead investigators of the clinical trial which led to the drug receiving breakthrough status from the FDA.[30]

In January 2016, researchers at Moffitt teamed up with the state of Florida in a study to see if making fruits and vegetables available to children who otherwise may not have them readily available can decrease their risk of cancer.[31]

In October 2017, the Food and Drug Administration announced the approval of Yescarta™, a revolutionary new immunotherapy for adult patients with diffuse large B cell lymphoma, a form of non-Hodgkin's lymphoma. Yescarta is a Chimeric Antigen Receptor (CAR) T cell therapy, also known as CAR-T. Moffitt Cancer Center's Frederick Locke, is the co-lead investigator of the pivotal ZUMA-1 clinical trial that tested the new therapy, which is manufactured by Kite, a Gilead company.[32]

In February 2024, the U.S. Food and Drug Administration approved a first-of-its-kind immunotherapy pioneered at Moffitt for patients with advanced melanoma.[33] Moffitt was a driving force in getting lifileucel (Amtagvi) FDA-approved for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.[34]

Notable patients

[edit]

Locations

[edit]

Moffit Cancer Center is located on the campus of the University of South Florida in north Tampa. The center includes the hospital, Muriel Rothman Building (clinic), Vincent A. Stabile Research Building and the Moffitt Research Center.[38]

Moffitt at International Plaza is a 50,000-square-foot full service outpatient facility near Tampa International Airport. The facility includes physician office visits, infusion services, radiation and radiology.[39]

McKinley Outpatient Center

Moffitt Cancer Center Prevention Research, Fowler Campus, located in north Tampa, is a facility that practices research for prevention and early detection of cancer.[40]

The Richard M. Schulze Family Foundation Outpatient Center at McKinley Campus,[41] 10920 N. McKinley Drive, includes the breast and skin cancer clinics, infusion center, research labs and four surgery suites.[42]

Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System, 801 N. Flamingo Road, Pembroke Pines, FL, provides a comprehensive Blood and Marrow Transplant Cellular Therapy Program for South Florida residents.[43]

Moffitt Cancer Center at Wesley Chapel, 2590 Healing Way, Wesley Chapel, FL, is a 28,000-square-foot outpatient facility bringing access to Moffitt expertise and nationally-ranked cancer care to Pasco County.[44]

Moffitt McKinley Hospital, 10901 N. McKinley Drive, Tampa, FL, is an inpatient surgical hospital located on Moffitt's McKinley Campus. The 10-story, 500,000-square-foot facility provides patients with the latest innovations in surgical techniques and inpatient care.[45]

Moffitt Cancer Center at Port Tampa Bay, 651 Channelside Drive, Tampa, FL, is a community outreach and education center near downtown Tampa.[46]

Recognition

[edit]
  • From 1999 to 2019, Moffitt has been ranked one of "America's Best Hospitals" for cancer by U.S. News & World Report.[47]
  • In 2014, Becker's Hospital Review includes Moffitt in the 100 Accountable Care Organizations to Know.[48]
  • In 2015, Moffitt earned a Magnet designation for nursing excellence, granted by the American Nurses Credentialing Center (ANCC), the credentialing body of the American Nurses Association.[49][verification needed]
  • In 2015, Becker's Hospital Review recognizes Moffitt's president and CEO Dr. Alan List in its "100 Physician Leaders of Hospitals and Health Systems."[50]
  • Moffitt Cancer Center was named 2017 Nonprofit of the Year by the Tampa Bay Business Journal. Moffitt was also recognized as the category winner in the Health & Human Services category.[51]
  • In 2018, Moffitt was named LGBTQ Healthcare Equality Leader by the Human Rights Campaign Foundation.[52] The cancer center was also named one of Working Mother Magazine's 100 Best Companies for 10th time.[53]
  • In 2023, Moffitt was ranked No. 10 in the nation and the top-ranked cancer hospital in Florida and the Southeast in Newsweek’s 2023 list of “America’s Best Cancer Hospitals.”[54]

See also

[edit]

References

[edit]
  1. ^ Reeves, Megan (20 August 2020). "Moffitt Cancer Center selects a new CEO, Dr. Patrick Hwu". Tampa Bay Times. Times Publishing Company. Retrieved 5 August 2022.
  2. ^ "About Us - Our Story". Moffitt Cancer Center. Archived from the original on 2014-03-13. Retrieved 2014-03-13.
  3. ^ "Cancer Centers". American Cancer Society. 7 September 2023.
  4. ^ "National Cancer Institute - Moffitt Cancer Center". American Cancer Society. 26 July 2012.
  5. ^ "NCI Cancer Centers by State". 7 September 2023.
  6. ^ "Best Hospitals for Cancer". U.S. News & World Report. 2018.
  7. ^ "U.S. News & World Report".
  8. ^ "Article". The Tampa Times. February 5, 1979.
  9. ^ "About Us - Our Story". Moffitt Cancer Center. Archived from the original on 2014-03-13. Retrieved 2014-03-13.
  10. ^ Wilson, Kirby (March 12, 2022). "Florida to spend more than $700 million on Pasco Moffitt cancer complex". Tampa Bay Times.
  11. ^ "Query Form - NIH RePORTER - NIH Research Portfolio Online Reporting Tools Expenditures and Results". projectreporter.nih.gov. Retrieved 2019-05-24.
  12. ^ "Cancer Treatment & Research". Moffitt Cancer Center.
  13. ^ "UF announces partnership with Moffitt". Archived from the original on 2008-07-05. Retrieved 2008-01-24.
  14. ^ "Moffitt Cancer Center, Shands HealthCare, University Of Florida Partner To Improve Cancer Care". Medical News Today.
  15. ^ "年齢を重ねるごとに不安なマッチングアプリをバレないで利用する秘訣 – 年齢を重ねるごとに不安なマッチングアプリをバレないで利用する秘訣について".
  16. ^ USF, Moffitt get grant for minority health center
  17. ^ "Moffitt Cancer Center | USF Health". health.usf.edu. Retrieved 5 August 2022.
  18. ^ "USF And Moffitt Cancer Center To Introduce New Center Of Excellence". Moffitt Cancer Center. 21 October 2009. Retrieved 5 August 2022.
  19. ^ "Tampa cancer center opens first bone marrow transplant clinic in Puerto Rico". Los Angeles Times. Archived from the original on 2011-05-29.
  20. ^ "New Moffitt facility near International Plaza means convenience, technology for cancer patients". Archived from the original on July 5, 2011.
  21. ^ "Moffitt Cancer Center project is the Rx for a sluggish economy". Tampa Bay Business Journal.
  22. ^ "Archived copy". Archived from the original on 2015-03-20. Retrieved 2012-09-10.{{cite web}}: CS1 maint: archived copy as title (link)
  23. ^ "Moffitt Cancer Center to start construction on $74.2 million outpatient facility". Tampa Bay Times. 30 January 2013.
  24. ^ Small touches for patients are the pride of Moffitt's new outpatient center
  25. ^ "Renowned Moffitt Cancer Center, Memorial Healthcare partner to expand cancer care in Florida". Healthcare Finance News.
  26. ^ "Moffitt Cancer Center selects a new CEO, Dr. Patrick Hwu". Tampa Bay Times. Retrieved 2022-10-06.
  27. ^ "FDA approval of revolutionary two-drug combo to treat advanced melanoma". ScienceDaily.
  28. ^ "Melanoma's Promising Pill on Medical News Corporate". Archived from the original on 2011-11-06. Retrieved 2015-05-04.
  29. ^ "Study Makes Case for Gardasil HPV Vaccine in Young Men". EverydayHealth.com.
  30. ^ "Moffitt Involved in Clinical Trials Leading to Fast-Tracked FDA Approval of Melanoma Drug | Tampa Bay Partnership". Archived from the original on 2015-04-02. Retrieved 2015-09-08.
  31. ^ Schreiner, Mark (20 January 2016). "Moffitt Cancer Center Teams With State To Look At Food Deserts". wusfnews.wusf.usf.edu.
  32. ^ "The FDA Just Approved a New Way of Fighting Cancer Using Personalized Gene Therapy". Time.
  33. ^ "FDA approval opens new melanoma therapy to more patients at Moffiitt Cancer Center". Spectrum News. 2024-02-26. Retrieved 2024-04-28.
  34. ^ "Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma". Journal of Clinical Oncology. September 2021. doi:10.1200/JCO.21.00612. PMID 34492205. Retrieved 2024-04-28.
  35. ^ Ortega, Tony (6 December 2022). "Kirstie Alley, OT 8 and one of Scientology's most iconic celebs, dead at 71". tonyortega.substack.com. Underground Bunker. Archived from the original on 6 December 2022. Retrieved 6 December 2022.
  36. ^ "Florida First Lady Casey DeSantis' breast cancer diagnosis could save lives, Tampa doctor says". WFLA. 2021-10-05. Retrieved 2022-10-06.
  37. ^ "Keylla Hernández enfrenta nuevo diagnóstico de cáncer". Primera Hora. 18 May 2016.
  38. ^ "Moffitt Cancer Center at International Plaza Tampa FL - Cancer Center Near Me". Moffitt Cancer Center.
  39. ^ QUINN CHAMBERLAIN, ALEXIS (12 July 2011). "Moffitt Cancer Clinic Opens Near International Plaza". 83Degrees. Retrieved 2017-09-25.
  40. ^ "Moffitt Cancer Center Prevention Research". Moffitt Cancer Center. Archived from the original on 2014-10-06. Retrieved 2017-09-25.
  41. ^ "Richard M. Schulze Family Foundation gives $6 million to Moffitt – The Cancer Letter Publications". cancerletter.com.
  42. ^ Manning, Margie (2 November 2015). "Inside Moffitt's new outpatient center". www.bizjournals.com. Retrieved 2017-09-25.
  43. ^ Chang, Daniel. "Cancer care alliance to offer blood and marrow transplantation, cellular therapy". miamiherald.
  44. ^ White, D'Ann. "Moffitt Cancer Center Opens Satellite Campus In Wesley Chapel". patch.
  45. ^ Muckle, Shauna. "Inside Moffitt Cancer Center's new McKinley hospital". tampabaytimes.
  46. ^ "Moffitt Cancer Center Teams Up with Port Tampa Bay and the Tampa Bay Lightning to Bring Cancer Community Outreach to Channelside". porttampabay. 18 November 2022.
  47. ^ "H. Lee Moffitt Cancer Center and Research Institute, Nationally Ranked in 4 Specialties". usnews.com. Archived from the original on 2012-09-16. Retrieved 25 September 2017.
  48. ^ Gordon, Molly Gamble, Heather Punke, Ayla Ellison, Akanksha Jayanthi and Dani (13 August 2014). "100 accountable care organizations to know | 2014". www.beckershospitalreview.com. Retrieved 2017-09-25.{{cite web}}: CS1 maint: multiple names: authors list (link)
  49. ^ "Moffitt Cancer Center Achieves Prestigious Nursing Magnet Recognition | Tampa Bay Partnership". Archived from the original on 2015-04-04. Retrieved 2015-04-06.
  50. ^ Staff (3 November 2015). "100 physician leaders of hospitals and health systems 2015". www.beckershospitalreview.com. Retrieved 2017-09-25.
  51. ^ "Non profit of the year" (PDF). 2017. Retrieved 2019-05-24.
  52. ^ Campaign, Human Rights. "Leaders in LGBTQ Healthcare Equality". Human Rights Campaign.
  53. ^ "6 best hospitals for mothers to work for". www.beckershospitalreview.com. 26 September 2018.
  54. ^ "Americas Best Cancer Hospitals". www.newsweek.com. 28 June 2023.
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=H._Lee_Moffitt_Cancer_Center_%26_Research_Institute&oldid=1233952405"